Eledon Pharmaceuticals Inc. (NASDAQ: ELDN)
$4.2750
+0.0050 ( +2.52% ) 262.3K
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
Market Data
Open
$4.2750
Previous close
$4.2700
Volume
262.3K
Market cap
$255.09M
Day range
$3.9500 - $4.3100
52 week range
$1.5199 - $5.5400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Dec 20, 2024 |
4 | Insider transactions | 1 | Nov 22, 2024 |
4 | Insider transactions | 1 | Nov 22, 2024 |
4 | Insider transactions | 1 | Nov 22, 2024 |
4 | Insider transactions | 1 | Nov 22, 2024 |
10-q | Quarterly Reports | 73 | Nov 12, 2024 |
8-k | 8K-related | 13 | Nov 12, 2024 |
4 | Insider transactions | 1 | Oct 31, 2024 |
8-k | 8K-related | 18 | Oct 30, 2024 |
8-k | 8K-related | 13 | Oct 29, 2024 |